2014
DOI: 10.1016/j.ejcdt.2014.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Role of epidermal growth factor receptor in malignant pleural mesothelioma and its value for successful chemical pleurodesis

Abstract: Background: The most common primary malignant tumor of the pleura is malignant mesothelioma. It is a highly aggressive tumor that has become a very important issue over recent years. Evidence suggests that EGFR is involved in the pathogenesis and progression of different carcinomas.Aim of the work: To study the role of EGFR in MPM and to investigate its value for successful chemical pleurodesis.Patients and Methods: This study included 53 patients with exudative pleural effusion. All were subjected to full his… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…Mechanisms of deregulation involve sustained activation of autocrine and paracrine signaling [ 21 ]. Among others, dysregulation of receptor tyrosine kinase (RTK) signaling results in abnormal activation of the PI3K/Akt/mTOR, and MAPK pathways [ 62 , 89 , 90 ]. These pathways regulate critical biological processes such as transcription, translation, cell proliferation, growth, and migration that are often deregulated in MPM.…”
Section: Genomics Of Malignant Pleural Mesotheliomamentioning
confidence: 99%
“…Mechanisms of deregulation involve sustained activation of autocrine and paracrine signaling [ 21 ]. Among others, dysregulation of receptor tyrosine kinase (RTK) signaling results in abnormal activation of the PI3K/Akt/mTOR, and MAPK pathways [ 62 , 89 , 90 ]. These pathways regulate critical biological processes such as transcription, translation, cell proliferation, growth, and migration that are often deregulated in MPM.…”
Section: Genomics Of Malignant Pleural Mesotheliomamentioning
confidence: 99%